Cresco Labs (CRLBF) Shares Outstanding (2019 - 2026)
Cresco Labs' (CRLBF) quarterly Shares Outstanding (Entity) came in at $364.2 million in Q1 2026, up 3.99% YoY from $350.2 million in Q1 2025, and up 6.12% on a QoQ basis from $343.2 million in Q4 2025.
Cresco Labs (CRLBF) Shares Outstanding (2019 - 2026) Analysis & Trends
Cresco Labs (CRLBF) has 8 years of Shares Outstanding (Entity) data on file, last reported at $364.2 million in Q1 2026.
- Quarterly Shares Outstanding (Entity) rose 3.99% year-over-year to $364.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $364.2 million (up 3.99% YoY) and the FY2025 annual result came in at $343.2 million, up 3.54% from the prior year.
- Shares Outstanding (Entity) rose to $364.2 million in Q1 2026, from $343.2 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $364.2 million in Q1 2026 to a low of $281.0 million in Q4 2022.
- A 5-year average of $328.3 million and a median of $337.5 million in 2023 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) rose 23.15% — and 2025, when it grew 2.35%.
- Tracing CRLBF's Shares Outstanding (Entity) over 5 years: stood at $281.0 million in 2022, then advanced by 14.15% to $320.8 million in 2023, then increased by 3.35% to $331.5 million in 2024, then gained by 3.54% to $343.2 million in 2025, then increased by 6.12% to $364.2 million in 2026.
- The last three Shares Outstanding (Entity) figures came in at $364.2 million (Q1 2026), $343.2 million (Q4 2025), and $355.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 832.44 Mn |
| 10 | Cresco Labs | 291.27 Mn | 227.16 Mn | 86.95 Mn | 370.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 364.23 Mn |
| Dec 31, 2025 | 355.01 Mn |
| Sep 30, 2025 | 355.54 Mn |
| Jun 30, 2025 | 354.29 Mn |
| Mar 31, 2025 | 350.24 Mn |
| Dec 31, 2024 | 345.47 Mn |
| Sep 30, 2024 | 347.36 Mn |
| Jun 30, 2024 | 344.93 Mn |
| Mar 31, 2024 | 341.63 Mn |
| Dec 31, 2023 | 323.82 Mn |
| Sep 30, 2023 | 337.47 Mn |
| Jun 30, 2023 | 313.62 Mn |
| Mar 31, 2023 | 304.71 Mn |
| Dec 31, 2022 | 298.16 Mn |
| Sep 30, 2022 | 301.12 Mn |
| Jun 30, 2022 | 296.32 Mn |
| Mar 31, 2022 | 292.72 Mn |
| Dec 31, 2021 | 262.33 Mn |
| Sep 30, 2021 | 271.18 Mn |
| Jun 30, 2021 | 260.04 Mn |